Cue Biopharma, Inc.
CUE
$0.768
-$0.0004-0.05%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.50M | -8.66M | -10.17M | -12.35M | -13.43M |
| Total Depreciation and Amortization | 2.05M | -1.41M | 1.61M | 99.00K | 2.99M |
| Total Amortization of Deferred Charges | 9.00K | 10.00K | 9.00K | 9.00K | 9.00K |
| Total Other Non-Cash Items | -691.00K | 3.81M | 1.04M | 2.73M | 121.00K |
| Change in Net Operating Assets | -901.00K | -1.27M | -2.48M | -274.00K | -647.00K |
| Cash from Operations | -9.03M | -7.53M | -9.99M | -9.78M | -10.96M |
| Capital Expenditure | -2.00K | 1.00K | -10.00K | -55.00K | -- |
| Sale of Property, Plant, and Equipment | 1.00K | 97.00K | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -1.00K | 98.00K | -10.00K | -55.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -999.00K | -1.00M | -1.00M | -1.00M | -1.00M |
| Issuance of Common Stock | 67.00K | 10.82M | 0.00 | 3.35M | 5.78M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -932.00K | 9.82M | -1.00M | 2.35M | 4.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.96M | 2.39M | -11.00M | -7.49M | -6.18M |